Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07579754 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Start date changed from estimate of Jul 2026 to Jul 14, 2026
    • Site details revised
    v4
  2. Start date: Jun 2026 to Jul 2026v3
  3. Start date: May 2026 to Jun 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
Trial Details
NCT Number NCT07579754
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute of Mental Health (NIMH), Kamuzu University of Health Sciences, Johns Hopkins Research Project, Malawi, Washington University School of Medicine
Conditions
(from sponsor)		 Long-acting Injectable Cabotegravir for PrEP, Oral Pre-Exposure Prophylaxis (PrEP)
Enrollment 384 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov